BRIEF-Takeda Pharmaceutical Co Ltd receives positive CHMP opinion for ADCETRIS
May 27, 2016 at 08:40 AM EDT
* Takeda receives positive CHMP opinion for ADCETRIS as consolidation treatment in post-transplant hodgkin lymphoma Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
